1
|
Misirlioglu NF, Orucoglu GG, Bıcakhan B, Kucuk SH, Himmetoglu S, Sayili SB, Ozen GD, Uzun H. Evaluation of Thrombomodulin, Heart-Type Fatty-Acid-Binding Protein, Pentraxin-3 and Galectin-3 Levels in Patients with Myocardial Infarction, with and Without ST Segment Elevation. J Clin Med 2025; 14:1015. [PMID: 39941683 PMCID: PMC11818096 DOI: 10.3390/jcm14031015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2024] [Revised: 01/19/2025] [Accepted: 02/02/2025] [Indexed: 02/16/2025] Open
Abstract
Background: Medical history, ECG findings and cardiac markers are used in the diagnosis of myocardial infarction (MI). Biomarkers used especially for the diagnosis of MI include high-sensitivity troponins (hsTns), creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH), myoglobin, cardiac myosin-binding protein C and new cardiac biomarkers. This study evaluated the levels of serum thrombomodulin (TM), heart-type fatty-acid-binding protein (H-FABP), pentraxin-3 (PTX-3) and galectin-3 (Gal-3) to determine their utility in distinguishing between ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI). Methods: This study included a total of 180 patients (90 patients with acute STEMI and 90 patients with NSTEMI) who presented to the Gaziosmanpaşa Training and Research Hospital, Cardiovascular Surgery and Emergency Department, with ischemic chest pain lasting longer than 30 min. Ninety healthy volunteers were included as the control group. Results: Serum levels of N-terminal pro-brain natriuretic peptide (NT-proBNP), TM, H-FABP, PTX-3 and Gal-3 were significantly different across the STEMI, NSTEMI and control groups (p < 0.001). Strong positive correlations were observed between NT-proBNP and TM, H-FABP, PTX-3 and Gal-3 in the STEMI group. ROC analysis demonstrated excellent diagnostic accuracy for these biomarkers in distinguishing STEMI from NSTEMI and control groups. Conclusions: Vascular inflammation plays an important role in the pathophysiology of STEMI and NSTEMI. A comprehensive cardiac biomarker panel enhances diagnostic accuracy and risk stratification, particularly when distinguishing between STEMI and NSTEMI. The biomarkers hs-TnI, CK-MB, NT-proBNP, TM, H-FABP, PTX-3 and Gal-3 offer complementary information when used together as a panel. Further research and validation are essential to establish standardized protocols for their widespread use.
Collapse
Affiliation(s)
- Naile Fevziye Misirlioglu
- Department of Biochemistry, Gaziosmanpaşa Training and Research Hospital, University of Health Sciences, 34098 Istanbul, Turkey
| | - Gulbahar Guler Orucoglu
- Department of Emergency, Gaziosmanpaşa Training and Research Hospital, University of Health Sciences, 34098 Istanbul, Turkey;
| | - Burcu Bıcakhan
- Department of Cardiovascular Surgery, Gaziosmanpaşa Training and Research Hospital, University of Health Sciences, 34098 Istanbul, Turkey;
| | - Suat Hayri Kucuk
- Department of Biochemistry, Istanbul Physical Medicine and Rehabilitation Training and Research Hospital, University of Health Sciences, 34186 Istanbul, Turkey;
| | - Solen Himmetoglu
- Department of Medical Biochemistry, Faculty of Medicine, Biruni University, 34015 Istanbul, Turkey;
- Biruni University Research Center (B@MER), Biruni University, 34015 Istanbul, Turkey
| | - Sena Baykara Sayili
- Department of Emergency Medicine, Istanbul Training and Research Hospital, 34098 Istanbul, Turkey;
| | - Gulenay Defne Ozen
- Department of Psychology, McGill University, Montreal, QC H3A 1G1, Canada;
| | - Hafize Uzun
- Department of Medical Biochemistry, Faculty of Medicine, Istanbul Atlas University, 34403 Istanbul, Turkey;
| |
Collapse
|